Advertisement
UK markets close in 4 hours 52 minutes
  • FTSE 100

    7,830.73
    -46.32 (-0.59%)
     
  • FTSE 250

    19,285.49
    -165.18 (-0.85%)
     
  • AIM

    741.21
    -4.08 (-0.55%)
     
  • GBP/EUR

    1.1675
    -0.0008 (-0.07%)
     
  • GBP/USD

    1.2444
    +0.0005 (+0.04%)
     
  • Bitcoin GBP

    51,918.59
    +2,322.75 (+4.68%)
     
  • CMC Crypto 200

    1,333.34
    +20.71 (+1.60%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • DOW

    37,775.38
    +22.07 (+0.06%)
     
  • CRUDE OIL

    82.30
    -0.43 (-0.52%)
     
  • GOLD FUTURES

    2,396.40
    -1.60 (-0.07%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,713.91
    -123.49 (-0.69%)
     
  • CAC 40

    7,995.16
    -28.10 (-0.35%)
     

Why Novavax Stock Got Mashed on Monday

Novavax (NASDAQ: NVAX), an up-and-down coronavirus stock, had a down day on Monday. The vaccine specialist's share price took a 5% hit after the company reported earnings that fell short of expectations. For its second quarter, Novavax earned just under $186 million in total revenue, which was well under the more than $298 million in the same period last year.